May 2026

ERGSN's new K-Tourism Assets sector opens with Yangpyeong Soohyang The Hanok — a four-unit traditional hanok property roughly 45 minutes east of Seoul. Four stand-alone building types cover classic and premium footprints (25-pyeong and 30-pyeong) plus pet-friendly variants: Sopunghun, Soyojae, Gyeonwujae, and Punggyeonru. Every unit includes a hinoki cypress bath room, a full kitchen, and free WiFi.

The B2B angle is the annual gujwa-bunyang fractional-share program: a portfolio of scheduled annual-access rights structured as a share rather than a time-share. It is positioned for:

• Corporate retreat planners who want a predictable repeat venue for leadership offsites and strategy weeks.
• Hospitality portfolio operators adding Korean heritage stock to co-branded international packages.
• Cross-border family and incentive-travel programs that value the cultural anchor of a Korean hanok over a conventional hotel inventory.

Pilot inquiries in the first ten days of May concentrated in Korean domestic B2B and Japanese / Singaporean hospitality distributors. This is a first-of-its-kind listing for ERGSN — details on all four unit types are live on the sector page, with share-program terms available through the standard RFQ flow.

The K-Beauty sector transitions out of "sourcing" and into a live 16-SKU portfolio this edition, organised by skincare-routine sub-category for direct procurement browsing:

• Toner (DEMED Wonder Ceramid) · Ampoule (7 SKUs — DD'ELL EGF, DEMED Vitamin C / Collagen 30ml / Collagen 7ml×5 / Hyaluronic Soothing / Brightening / Spicule Peptide 300 Shot).
• Cream (DD'ELL Setup Creame, Glowup Cream; DEMED Extra Intense Moisture M8) · Primer (DD'ELL Filter Primer ZeroPore).
• Cushion (DD'ELL Dewy Glow, Line Lift) · Setting Mist (DD'ELL Mask Defense, Dewy Glow Fixer).

All 16 SKUs are manufactured by COSMEDIQUE Co., Ltd. (est. 1985) under Korean CGMP standards with OEM/ODM private-label terms available at MOQ 1,000 per SKU. The most active buyer cohort this month is LATAM duty-free channels and MENA premium-retail distributors testing Korean dermaceutical positioning against established French and Japanese lines.

The new sub-category filter on the K-Beauty grid lets procurement teams shortlist by routine step in a single view — the format that emerged as the highest-signal UX during the sprint.

RAY-1 Bio Cream joins the ERGSN catalog as the second live K-Bio SKU alongside Rosetta Plus HFF — but on a distinct track. Where Rosetta Plus targets regulated wellness retail through HACCP / KFDA HFF documentation, RAY-1 operates in the dermaceutical biotech-skincare category: topical cream, tube format, 100 ml net (~100 g), 24-month shelf life with 12-month PAO after opening.

The brand is owned by Iho Biotech Co., Ltd. (Seoul) and manufactured by Esthemiga. Full INCI ingredient disclosure and any functional-cosmetic attestations are available from the brand owner under NDA on the RFQ track, supporting buyer-side due diligence and OEM / private-label negotiations without exposing formulation to the public listing.

This listing opens the K-Bio sector to a dermaceutical channel that was previously absent from the catalog — relevant for hospital pharmacy channels, medi-spa portfolios, and premium-retail skincare buyers evaluating Korean biotech cream alongside their current DD'ELL / DEMED dermatological lines (see K-Beauty entry above).

HYGEN's April breakout (48% YoY) settles into a sustained 40% YoY pull this month — the same three buyer groups, the same configuration preferences, now with a deeper pipeline. European off-grid logistics yards continue pulling the dual-set combo (KE-Option C, ~2.4 kW/h) for continuous-load profiles; Australian remote-site operators re-quoting DC-coupled HYGEN arrays; GCC government facilities advancing bundled ESS pilots toward Q3 start.

Two signals worth flagging for buyers still evaluating the category:

• Price stability is extending — ERGSN holds Q3 2026 verified-partner pricing flat, which gives procurement teams a real planning window for capex lock-in.
• Configuration drift is minimal — the catalog's four options (A / B / C / D) still cover the full 1.0–3.6 kW/h band with predictable unit economics. No forcing function to custom-configure unless volume exceeds the flagship array.

For Korean makers considering the HYGEN segment: ERGSN's Verified Partner track is absorbing additional supply-side capacity through Q2–Q3 2026 to match the pipeline.

Two notes anchor this entry — one product, one operational. The product side is steady: DL Series (DL-10X through DL-16XD) continues carrying GSA Schedule sole-source eligibility for U.S. federal procurement, HIPAA workflow documentation for regulated healthcare networks, and DIN 66399 Level-3 / P-4 construction that Chinese-made consumer-grade shredders do not match. Lead times remain 4–6 weeks with individual crating for ocean freight.

The operational note: Partner Analytics Dashboard Phase 0 crosses from preview into live operation this month, with P-001 ERYUN as the first onboarded Korean manufacturer. The dashboard gives Verified Partners a token-URL view of their own live RFQ metrics backed by the ERGSN Cloudflare D1 store — KPIs, daily series, top buyer countries, and recent submissions filtered to their product CSV. No signup friction: ERGSN admin provisions each partner and hands the URL over direct Telegram or KakaoTalk.

For Korean makers who cleared the ERGSN 4-step verification and want to see where their own products are pulling global buyer interest, dashboard access ships with the Verified tier.